Best Katan Podcasts (2026)

Send us a text Two leaders from Sionna Therapeutics walk through a 15‑year journey from Genzyme science to a public company advancing NBD1‑targeted therapies in cystic fibrosis. We examine why most patients still fall short of normal CFTR, how a predictive assay de‑risks choices, and what it takes to finance, hire, and execute with patients as the …

1
Megillah 2.4-5

Play Pause

22d ago

—

By Rabbi Hertzka Greenfeld

1
Megillah 2.2-3

23d ago

—

By Rabbi Hertzka Greenfeld

1
Megillah 1.11-2.1

24d ago

—

By Rabbi Hertzka Greenfeld

1
Megillah 1.9-10

25d ago

—

By Rabbi Hertzka Greenfeld

1
Megillah 1.7-8

26d ago

—

By Rabbi Hertzka Greenfeld

1
Megillah 1.5-6

27d ago

—

By Rabbi Hertzka Greenfeld

1
Megillah 1.3-4

28d ago

—

By Rabbi Hertzka Greenfeld

1
Megillah 1.1-2

29d ago

—

By Rabbi Hertzka Greenfeld

1
Taanis 4.7-8

1M ago

—

By Rabbi Hertzka Greenfeld

1
Taanis 4.5-6

1M ago

—

By Rabbi Hertzka Greenfeld

1
Taanis 4.3-4

1M ago

—

By Rabbi Hertzka Greenfeld

1
Taanis 4.1-2

1M ago

—

By Rabbi Hertzka Greenfeld

1
Taanis 3.8-9

1M ago

—

By Rabbi Hertzka Greenfeld

1
Taanis 3.6-7

1M ago

—

By Rabbi Hertzka Greenfeld

1
AI Won’t Replace Writers, But Writers Who Use AI Will Outpace The Rest with Bilal Bham 24:03

1M ago24:03

24:03

Send us a text What if the documents behind a clinical trial were written with the patient’s voice in mind and delivered at the speed modern science deserves? We sit down with writer, consultant, and patient-advocate Bilal Bham to unpack how protocols, clinical trial applications, and clinical study reports actually get made, why structure beats ch…

1
Taanis 3.4-5

1M ago

—

By Rabbi Hertzka Greenfeld

1
Taanis 3.2-3

1M ago

—

By Rabbi Hertzka Greenfeld

1
Taanis 2.10-3.1

1M ago

—

By Rabbi Hertzka Greenfeld

1
From Grief To Global Advocacy For Clinical Research In Infectious Diseases with Christian John Lillis 31:04

2M ago31:04

31:04

Send us a text A routine dental visit, a few days of diarrhea, and then the unthinkable: septic shock and a life lost within 24 hours. Our guest, Christian John Lillis, shares how losing his mother Peggy to a community-acquired C. diff infection exposed a silent public health crisis and led him to co-found the Peggy Lillis Foundation (https://cdiff…

1
Decoding Real-World Evidence: Beyond Clinical Trials with Manfred Stapff 31:41

4M ago31:41

31:41

Send us a text What if millions of electronic health records could transform how we understand medicine? In this thought-provoking conversation with Dr. Manfred Stapff, physician and real-world evidence pioneer, we uncover how anonymized patient data is revolutionizing healthcare research. Dr. Stapff reveals how the 21st Century Cures Act dramatica…

1
Democratizing Drug Development Through AI-Native Platforms with Ilya Burkov 18:32

4M ago18:32

18:32

Send us a text Cloud computing is transforming biotech by offering purpose-built infrastructure that supports AI-driven drug discovery and development while meeting strict regulatory requirements. Dr. Ilya Burkov explains how Nebius provides full-stack solutions that democratize access to powerful technology, enabling researchers to achieve breakth…

1
Incorruptible Evidence: Blockchain's Promise for Faster Drug Approvals w. Dominik Lysek 27:44

5M ago27:44

27:44

Send us a text Dominik Lysek, CEO of PharmaTrail, explains how blockchain technology can solve trust issues in clinical trials by providing an incorruptible audit trail that verifies data integrity. This solution could significantly accelerate the time required for regulatory approvals, partnerships, and acquisitions, ultimately getting treatments …

1
Revolutionizing Dentistry: AI and Research Innovation with Dr. Shervin Molayem 38:48

5M ago38:48

38:48

Send us a text Dr. Shervin Molayem shares his journey of innovation in dentistry, starting with his discovery of a connection between periodontal disease and COVID-19 severity that became the world's most-read dental article of 2020. He discusses groundbreaking technologies including AI-powered diagnostic tools and a revolutionary non-surgical trea…

1
How early diagnostics of lung cancer can lead to better survival rates with Chris Wood 36:59

6M ago36:59

36:59

Send us a text Chris Wood discusses how early diagnostics of lung cancer through artificial intelligence and medical imaging can lead to better survival rates through early intervention. • Lung cancer takes more lives than breast, prostate and colon cancer combined, with approximately 70% of cases caught at late stages • The National Lung Screening…

1
From Hopeless to High-Performing: Transforming Pharma Teams with Rajesh Anandan and Nechama Katan 53:36

7M ago53:36

53:36

Send us a text Building high-performing teams in life sciences requires understanding how neurodiversity can be an advantage and designing work systems that enable different brain types to collaborate effectively. • A high-performing team continues to function when everything around it has fallen apart • Star players can become crutches that mask u…

1
Data Governance in the Age of Generative AI with Sebastian Andruszczak 36:08

7M ago36:08

36:08

Send us a text Sebastian Andruszczak, Chief Growth Officer at Holisticon (part of the Nexer Group), brings fresh perspective to the conversation around generative AI adoption in pharmaceutical companies. Drawing from his unique background in sales, marketing, and technology, Sebastian cuts through the hype to address fundamental challenges that pre…

1
Prevention Pays: How Technology Is Revolutionizing Mental Health with Eva Papadopoulou 27:14

8M ago27:14

27:14

Send us a text Why do we wait until we're severely unwell before seeking help? In this thought-provoking episode, I'm joined by Eva Papadopoulou, a mental health professional and expert in digital and AI-enabled healthcare solutions, to explore the transformative potential of preventative mental healthcare. Eva reveals the stark reality of our curr…

1
Creating virtuous cycles in drug development with Rob Freishtat 45:14

9M ago45:14

45:14

Send us a text Rob Freistat, President of Uncommon Cures, discusses how clinical trials are transforming to accelerate drug development and ensure patients receive treatments faster, particularly in the rare disease space. • Current market uncertainty and investment challenges in biotech, especially for rare disease research • Approximately two-thi…

1
Bridging Academia and Biotech: Creating Innovators of Tomorrow with Jonathon Hill 32:03

9M ago32:03

32:03

Send us a text Jonathan Hill takes us on a fascinating journey through the cutting-edge world of DNA sequencing and its revolutionary potential for early disease detection. As both an academic professor at Brigham Young University and co-founder of Wasatch BioLabs, Hill shares how third-generation sequencing technologies are transforming our abilit…

1
From Lab to Patient: Why Vector Design Makes or Breaks Cell Therapies with Alan Griffith 56:22

10M ago56:22

56:22

Send us a text Vectors are the unsung heroes of cell and gene therapy—molecular couriers that transport therapeutic genes into human cells to treat disease. But as Alan Griffith, Head of Global Operations at Vector Builder reveals, creating these sophisticated delivery vehicles is far more complex than most realize. Drawing from over a decade of ex…

1
Tomorrow's Cures Are Hiding in Today's Patient Records with Vish Srivastava 24:18

10M ago24:18

24:18

Send us a text The untapped potential of electronic health records has long been recognized in clinical research, but extracting meaningful insights from this treasure trove of data has remained an elusive challenge—until now. Vish Srivastava, founder of Century Health, reveals how artificial intelligence is revolutionizing real-world evidence by u…

1
Championing Diversity to Transform Clinical Research with Shelli Pavone 32:07

11M ago32:07

32:07

Send us a text Join us for a conversation with guest Shelli Pavone, co-founder of Inlightened, to uncover the untapped potential of diversity in clinical trials. Discover how historical mistrust, structural barriers, and exclusion criteria continue to hinder diverse patient recruitment. Shelli sheds light on the transformative impact inclusive tria…

1
Revolutionizing Neurological Care: Andreas Forsland and Gregg Johns on Assistive Technology and Brain-Computer Interfaces 56:23

11M ago56:23

56:23

Send us a text In this episode we dive into Brain-Computer Interface (BCI) technology, where the brain's faint signals are harnessed to create life-changing applications. Andreas Forsland and Greg Johns emphasize the importance of community-driven innovation, guided by the Brainiac Council—a unique assembly of patients, caregivers, and experts. Thi…

1
The Lost Episode of Summer: Smoked Meats, Andy Can't Stop, and "The LIST" part one! 39:30

11M ago39:30

39:30

Found a lost episode on my computer and it was so good I had to upload it even though it's six months old! The fall and winter have been incredibly busy for L & P (separately, not together), but we still love our listeners! In this, episode, we began the second of two series(es?) that we hooooope to continue soon! The last episode was Emotionally H…

1
Revolutionizing Patient Recruitment in Clinical Trials: Unlocking Access and Accelerating Drug Development with Jill Pellegrino 29:08

12M ago29:08

29:08

Send us a text This episode reveals alarming statistics about patient access to clinical trials, highlighting that only 3% of patients currently have access to participate. Our guest, Jill Pellegrino, CEO of Auto Recruitment, shares innovative strategies to engage the other 90% of the patient population and discusses the importance of digital adver…

1
Navigating the Shift: From SAS to R in Clinical Trials with Sunil Gupta 34:59

1y ago34:59

34:59

Send us a text Why has SAS been the cornerstone of clinical trials for decades, and what is causing the shift to R now? Join us on "Transformation in Trials" as we explore this pivotal transition with Sunil Gupta, a seasoned programmer who has navigated both worlds. Sunil elaborates on SAS's long-standing dominance due to its robust programming cap…